Problem statement: Answer the multiple choice question.
Query: Which drug exhibits a 14.320\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a: COc1ccc(-n2ncc3c(N4CCCCC4)ncnc32)cc1
b: CC(C)CNC(=O)C(=O)NCC1OCCCN1S(=O)(=O)c1cccs1
c: CCn1c(SCC(=O)N2CCCC2=O)nnc1-c1cccs1
Answer: b. CC(C)CNC(=O)C(=O)NCC1OCCCN1S(=O)(=O)c1cccs1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(C)CNC(=O)C(=O)NCC1OCCCN1S(=O)(=O)c1cccs1
CC(C)CNC(=O)C(=O)NCC1OCCCN1S(=O)(=O)c1cccs1
N'-(2-methylpropyl)-N-[(3-thiophen-2-ylsulfonyl-1,3-oxazinan-2-yl)methyl]oxamide